Dynavax Technologies
DVAX
DVAX was delisted on the 9th of February, 2026.
225 hedge funds and large institutions have $1.86B invested in Dynavax Technologies in 2023 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 85 increasing their positions, 65 reducing their positions, and 20 closing their positions.
515% more call options, than puts
Call options by funds: $13.4M | Put options by funds: $2.18M
65% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 20
31% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 65
13% more capital invested
Capital invested by funds: $1.64B → $1.86B (+$219M)
5% more funds holding
Funds holding: 215 → 225 (+10)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1.12% less ownership
Funds ownership: 98.95% → 97.84% (-1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$29M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$14M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$10.3M |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$10.3M |
| 5 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
+$8.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$34.9M |
| 2 |
Fisher Asset Management
Camas,
Washington
|
-$31.5M |
| 3 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$21.1M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$14.5M |
| 5 |
Goldman Sachs
New York
|
-$8.99M |
DVAX Hedge Fund Activity: Q3 2023 in Review
225 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2023, worth a combined $1.86B — up 13% from $1.64B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new DVAX positions and 20 closed out — a net gain of 13 holders — while 85 added to existing stakes and 65 trimmed.
The largest buyer was BlackRock, adding an estimated $29M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $34.9M sold.
- 225 institutional investors held Dynavax Technologies (DVAX) as of Q3 2023, up from 215 in Q2 2023.
- Funds reported $1.86B of Dynavax Technologies stock for Q3 2023, up 13% quarter-over-quarter.
- 33 funds opened new Dynavax Technologies positions in Q3 2023 and 20 closed out, a net change of +13 holders.
- The largest Dynavax Technologies buyer in Q3 2023 was BlackRock, an estimated $29M added.
- The largest Dynavax Technologies seller in Q3 2023 was PFM Health Sciences, an estimated $34.9M sold.
Based on aggregated 13F filings for Q3 2023.